Model creation & evaluation

Workpackage #5

Model creation & evaluation

Everything comes together in WP5. By applying cutting-edge AI and
machine learning techniques, this WP will model and analyse the data that
was collected in WP1, assembled in WP2, and facilitated by WP3 and WP4.

These models will aid in defining novel subgroups of CVD patients,
assessing CVD risk prediction, and predicting how patients respond to
treatment to improve outcomes based on individual biomarker profiles.
These models will be evaluated prospectively in WP6 (clinical validation).

Meet our team

Novo Nordisk

Katja Zilonova

Senior Research Scientist

Thomas More

Lieven De Maesschalck

Innovation Manager

Thomas More

Hajar Ghaem Sigarchian

AI Researcher and Lecturer

Decentriq

Maria Fernanda Scoz Luz

Business Development Manager

Decentriq

Nikolas Molyndris

Product Lead, Healthcare & Life science

Human Technopole

Emanuele Di Angelantonio

Head of Health Data Science Centre

Human Technopole

Giulia Mangiameli

Scientific Project Manager

TNO

Willem van den Brink, PhD

Netherlands Organisation for Applied Scientific Research

Philips

Pauline Porquet

Sr Business Development Manager Biomarkers

Roche

Norbert Krautenbacher, Dr.

Roche Diagnostics GmbH

University of Glasgow

Alasdair Henderson , Dr.

University of Glasgow

Maastricht University

Christof Peters, MD

Maastricht University

IMEC

John Morales

Researcher
Get updated

Our related news

30 January, 2025

First Patient Advisory Board meeting

Today marked a significant milestone for the iCARE4CVD project, as the newly..

28 January, 2025

Launch of Patient Panels – First meeting in Dublin

In iCARE4CVD, Patient Panels are groups of individuals living with CVD who..

10 September, 2024

New publication: Evaluating digital care for heart failure using patient experience measures – A scoping review

Heart failure (heart failure) is a serious condition that affects many people..

Subscribe to our newsletter

Subscribe to our newsletter to stay up to date with all the most recent information about iCARE4CVD.